J P Essepian1, R Rajpal, T P O'Brien. Show Affiliations » 1. Wilmer Eye Institute, Johns Hopkins University Hospital, Baltimore, Maryland 21287-9121, USA.
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, TopicalAnimalsCalcinosis/chemically inducedCalcinosis/pathologyChemical PrecipitationCiprofloxacin/adverse effectsCornea/drug effectsCornea/ultrastructureCorneal Diseases/chemically inducedCorneal Diseases/drug therapyCorneal Diseases/pathologyEpithelium/drug effectsEpithelium/ultrastructureHumansHydrogen-Ion ConcentrationMaleMicroscopy, ConfocalMiddle AgedNorfloxacin/adverse effectsOfloxacin/adverse effectsOphthalmic SolutionsRabbitsRandom AllocationTears/chemistryWound Healing/drug effects
Substances: See more » Ophthalmic SolutionsCiprofloxacinOfloxacinNorfloxacin
Year: 1995 PMID: 7671612 DOI: 10.1097/00003226-199507000-00009
Source DB: PubMed Journal: Cornea ISSN: 0277-3740 Impact factor: 2.651